Taysha Gene Therapies
Tracked across 2 events · 16 articles · First seen Apr 03, 2026 · Last active Jun 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Taysha Gene Therapies granted restricted stock units and stock options to four new employees as an inducement for their employment, which is a positive move for talent acquisition.
Apr 03, 2026 · 6 articles
Business
Impact: Taysha Gene Therapies is conducting a public offering of its common stock and pre-funded warrants to raise approximately $200.0 million, which will provide capital for its operations and gene therapy development.
Jun 24, 2026 · 10 articles
100
Taysha Gene Therapies announced public offeringTaysha Gene Therapies...
70
Taysha Gene Therapies granted stock unitsTaysha Gene Therapies...
60
Jefferies acted as manager Taysha Gene TherapiesTaysha Gene Therapies...
60
Goldman Sachs acted as manager Taysha Gene TherapiesTaysha Gene Therapies...
60
Piper Sandler Companies acted as manager Taysha Gene TherapiesTaysha Gene Therapies...
60
Cantor Fitzgerald acted as manager Taysha Gene TherapiesTaysha Gene Therapies...
40
Baird (investment bank) acted as lead manager Taysha Gene TherapiesTaysha Gene Therapies...
ERGEN INTELLIGENCE
Track Taysha Gene Therapies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard